Table 6 Impact of purchase gaps when up to 3 months of ectoparasite protection is purchased with gaps
From: An assessment of canine ectoparasiticide administration compliance in the USA
Product | Three-month dosing period including average gap duration (weeks) | Percentage of period protected |
|---|---|---|
Fluralaner 12-week dosinga | 12 | 100 |
Fluralaner 8-week dosingb | 28.8 | 56 |
Afoxolaner | 35.7 | 36 |
Sarolaner | 49.6 | 26 |
Lotilaner | 28.3 | 46 |